PMID- 19853606 OWN - NLM STAT- MEDLINE DCOM- 20100216 LR - 20211020 IS - 1090-2430 (Electronic) IS - 0014-4886 (Print) IS - 0014-4886 (Linking) VI - 221 IP - 1 DP - 2010 Jan TI - Hepatocyte growth factor (HGF) modulates GABAergic inhibition and seizure susceptibility. PG - 129-35 LID - 10.1016/j.expneurol.2009.10.011 [doi] AB - Disrupted ontogeny of forebrain inhibitory interneurons leads to neurological disorders, including epilepsy. Adult mice lacking the urokinase plasminogen activator receptor (Plaur) have decreased numbers of neocortical GABAergic interneurons and spontaneous seizures, attributed to a reduction of hepatocyte growth factor/scatter factor (HGF/SF). We report that by increasing endogenous HGF/SF concentration in the postnatal Plaur null mouse brain maintains the interneuron populations in the adult, reverses the seizure behavior and stabilizes the spontaneous electroencephalogram activity. The perinatal intervention provides a pathway to reverse potential birth defects and ameliorate seizures in the adult. FAU - Bae, Mihyun H AU - Bae MH AD - Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. FAU - Bissonette, Gregory B AU - Bissonette GB FAU - Mars, Wendy M AU - Mars WM FAU - Michalopoulos, George K AU - Michalopoulos GK FAU - Achim, Cristian L AU - Achim CL FAU - Depireux, Didier A AU - Depireux DA FAU - Powell, Elizabeth M AU - Powell EM LA - eng GR - UL1 TR000005/TR/NCATS NIH HHS/United States GR - MH57689/MH/NIMH NIH HHS/United States GR - R01 MH057683-07/MH/NIMH NIH HHS/United States GR - R01 DA018826-04/DA/NIDA NIH HHS/United States GR - R01 MH057683/MH/NIMH NIH HHS/United States GR - R01 DA018826/DA/NIDA NIH HHS/United States GR - DA018826/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20091022 PL - United States TA - Exp Neurol JT - Experimental neurology JID - 0370712 RN - 0 (Glial Fibrillary Acidic Protein) RN - 0 (Parvalbumins) RN - 0 (Plaur protein, mouse) RN - 0 (Receptors, Urokinase Plasminogen Activator) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - 67256-21-7 (Hepatocyte Growth Factor) RN - WM5Z385K7T (Pentylenetetrazole) SB - IM MH - Action Potentials/drug effects/genetics MH - Analysis of Variance MH - Animals MH - Animals, Genetically Modified MH - Animals, Newborn MH - Avoidance Learning/physiology MH - Brain/cytology/metabolism MH - Disease Susceptibility/*metabolism MH - Electroencephalography/methods MH - Enzyme-Linked Immunosorbent Assay/methods MH - Glial Fibrillary Acidic Protein/metabolism MH - Hepatocyte Growth Factor/*metabolism/pharmacology MH - Humans MH - Interneurons/drug effects/*physiology MH - Mice MH - Neural Inhibition/*physiology MH - Parvalbumins/metabolism MH - Pentylenetetrazole MH - Reaction Time/drug effects MH - Receptors, Urokinase Plasminogen Activator/genetics MH - Seizures/chemically induced/genetics/*metabolism/pathology MH - gamma-Aminobutyric Acid/*metabolism PMC - PMC2812579 MID - NIHMS155609 EDAT- 2009/10/27 06:00 MHDA- 2010/02/17 06:00 PMCR- 2011/01/01 CRDT- 2009/10/27 06:00 PHST- 2009/07/31 00:00 [received] PHST- 2009/10/10 00:00 [revised] PHST- 2009/10/15 00:00 [accepted] PHST- 2009/10/27 06:00 [entrez] PHST- 2009/10/27 06:00 [pubmed] PHST- 2010/02/17 06:00 [medline] PHST- 2011/01/01 00:00 [pmc-release] AID - S0014-4886(09)00428-2 [pii] AID - 10.1016/j.expneurol.2009.10.011 [doi] PST - ppublish SO - Exp Neurol. 2010 Jan;221(1):129-35. doi: 10.1016/j.expneurol.2009.10.011. Epub 2009 Oct 22.